Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 978 participants.
Also called NCT07002476
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 978 participants
- Sponsor
- Registry
-
NCT07002476
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07002476. Randomized; single masking; primary purpose treatment. Start 2025-06-19 (actual); primary completion 2027-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion
- Acronym
- EAST-LDL
- Condition
- Stroke
- Intervention (Drug)
- guideline-recommended SoC
- Intervention (Drug)
- Recaticimab (intensive)
- Lead sponsor
- Shanghai East Hospital
Record details
- Record id
cardio:ct-nct07002476- Content hash
392b3fb61e8fe197de2a426f39e3e987e89ec2fb59b54bcad2ea77b4a8b83516